Aveo logo
Startup

Aveo

See Aveo's full profile

BOOK A DEMO
Headquarters

Germany

Founded Year

2021

Total Funding

Employees Status

Active


About Aveo

Aveo gives manufacturers the tools to uplevel their current workforce from within to become drivers of innovation and to live up to their full potential.

Headquarters

Weinbergsweg 24, 10119 Berlin, Germany


General Information on Aveo

Brand name Aveo
Company name Dekant Ventures UG (haftungsbeschränkt)
Register number HRB 226644
Website https://aveo.one/
Founded year 2021
Employees None
Contact [email protected]
+4915141910407

Find startup solutions in your specific business context

The INNOSPOT Startup Discovery platform helps you to find the right startup solutions by leveraging the world's most powerful Startup Search Engine analyzing millions of data points.
BOOK A DEMO

Recent News and Activity about Aveo

Arabam 08.12.2022
Galeriden Chevrolet Aveo 1.4 SE 2011 Model İstanbul

ARAC TEMİZ 2011 MODEL SAHİBİNDEN SATILIK 1 PARCA DEĞİŞEN SON SÖFÖR KAPISI 3 PARCA BOYA SOL ON CAMURLUK SON ARKA KAP SOL ARKA CAMURLUK BAŞKA BOYA YOK 6 BİN CIVARI HASAR KAYDI VAR MUANESİ 2024/10 AYA KADAR ALICIYA HAYIRLI OLSUN TAKAS OLUR

Defense World 03.12.2022
AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) Given Consensus Recommendation of “Hold” by Analysts

Shares of AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO – Get Rating) have been assigned a consensus recommendation of “Hold” from the six brokerages that are currently covering the stock, Marketbeat reports. Six investment analysts have rated the stock with a hold recommendation. The average 12-month target price among analysts that have issued ratings on the stock in the last year is $15.00. Several research analysts recently commented on AVEO ...

Aveo news
ETF Daily News 03.12.2022
AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) Receives Average Rating of “Hold” from Analysts

Shares of AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO – Get Rating) have been given an average recommendation of “Hold” by the six ratings firms that are presently covering the company, Marketbeat Ratings reports. Six research analysts have rated the stock with a hold rating. The average 1 year price target among brokerages that have issued ratings on the stock in the last year is $15.00. A number of research firms have weighed in on AVEO. Robert ...

American Banking News 03.12.2022
StockNews.com Lowers AVEO Pharmaceuticals (NASDAQ:AVEO) to Hold

StockNews.com lowered shares of AVEO Pharmaceuticals ( NASDAQ:AVEO – Get Rating from a buy rating to a hold rating in a research report sent to investors on Wednesday morning. A number of other research analysts have also recently commented on the company. HC Wainwright cut AVEO Pharmaceuticals from a buy rating to a neutral rating in a research note on Tuesday, October 18th. Jonestrading cut AVEO Pharmaceuticals from a buy rating to a hold ...

Market Screener 02.12.2022
AVEO Pharmaceuticals : Merger Agreement - Form 8-K

12/02/2022 | 09:14am EST 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 1, 2022 AVEO Pharmaceuticals, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) (Commission File Number) (IRS ...

Thelincolnianonline 02.12.2022
AVEO Pharmaceuticals (NASDAQ:AVEO) Reaches New 12-Month High at $14.95

AVEO Pharmaceuticals, Inc. ( NASDAQ:AVEO – Get Rating ) shares hit a new 52-week high on Wednesday. The stock traded as high as $14.95 and last traded at $14.95, with a volume of 1203418 shares changing hands. The stock had previously closed at $14.87. Analysts Set New Price Targets AVEO has been the subject of several analyst reports. SVB Leerink cut shares of AVEO Pharmaceuticals from an “outperform” rating to a “market perform” rating in a ...

Swissquote (Switzerland) (German) 02.12.2022
BRIEF-Aveo Oncology - Effective As Of 1159 P.M. Eastern Time On December 1, 2022, Waiting Period Under Hart-Scott-Rodino Act Expired With Respect To Lg Chem Merger

Dec 2- Aveo Pharmaceuticals Inc:* AVEO ONCOLOGY- EFFECTIVE AS OF 11:59 P.M. EASTERN TIME ON DECEMBER 1, 2022, WAITING PERIOD UNDER HART-SCOTT-RODINO ACT EXPIRED WITH RESPECT TO LG CHEM MERGER

MarketScreener 02.12.2022
AVEO PHARMACEUTICALS, INC. : Other Events (form 8-K) | MarketScreener

As previously disclosed, on , , a corporation ("AVEO"), entered into an Agreement and Plan of Merger (the "Merger Agreement") with LG Chem, Ltd., a corporation organized and existing under the laws of the ("LG Chem"), and , a corporation and a wholly owned subsidiary of LG Chem ("Merger Sub"), pursuant to and subject to the terms and conditions of which Merger Sub will be merged with and into AVEO, with AVEO surviving the merger as an indirect ...

Aveo news
MarketScreener 02.12.2022
AVEO Pharmaceuticals : Merger Agreement - Form 8-K | MarketScreener

of the Securities Exchange Act of 1934 Check the appropriate box below if the Form 8-Kfiling is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Securities registered pursuant to Section 12(b) of the Act: Indicate by check mark whether the registrant is an emerging growth company as defined in ...

Aveo news
Community Financial News 30.11.2022
AVEO Pharmaceuticals (NASDAQ:AVEO) Reaches New 12-Month High at $14.95

AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO – Get Rating)’s share price hit a new 52-week high on Wednesday . The stock traded as high as $14.95 and last traded at $14.95, with a volume of 1203418 shares traded. The stock had previously closed at $14.87. A number of research analysts have commented on AVEO shares. Robert W. Baird cut AVEO Pharmaceuticals from an “outperform” rating to a “neutral” rating in a research note on Tuesday, October 18th. ...

Aveo news